中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Volume 37 Issue 3
Mar.  2021
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(3): 654-659

Association of the duration of systemic inflammatory response syndrome with infectious pancreatic necrosis at the initial stage of acute pancreatitis

DOI: 10.3969/j.issn.1001-5256.2021.03.029

  • Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China

  • Received Date: 2020-08-27
  • Accepted Date: 2020-10-20
  • Published Date: 2021-03-20
    Abstract
  •   Objective  To investigate the potential association between early-stage inflammatory response and late-stage infectious pancreatic necrosis (IPN) in patients with acute pancreatitis (AP).  Methods  A retrospective analysis was performed for the clinical data of 219 patients with moderate-severe acute pancreatitis (MSAP) and 53 patients with severe acute pancreatitis (SAP) who were admitted to The Affiliated Hospital of Southwest Medical University from June 2019 to June 2020, and according to the presence or absence of systemic inflammatory response syndrome (SIRS) at the initial stage of the disease, they were divided into SIRS group with 160 patients and non-SRIS group with 112 patients. Baseline data, serological markers, complications, and mortality rate were included for analysis. The t-test or the Mann-Whitney U test was used for comparison of continuous data between two groups; the chi-square test was used for comparison of categorical data between multiple groups, and the Bonferroni method was used for further comparison between two groups. A logistic regression analysis was used to screen out valuable variables; the receiver operating characteristic (ROC) curve was used to compare the diagnostic value of variables, and the Z-test was used for pairwise comparison of area under the ROC curve (AUC).  Results  Compared with the non-SIRS group, the SIRS group had significantly higher white blood cell count (WBC), C-reactive protein (CRP), and procalcitonin (all P < 0.05) and a significantly higher proportion of patients with acute peripancreatic necrosis (ANC), IPN, pancreatic necrosis (PN), organ dysfunction, multiple organ dysfunction syndrome (MODS), SAP, critically-ill acute pancreatitis (CAP), death, BISAP score > 2, CTSI score > 2, or RANSON score > 2 (all P < 0.05). The univariate analysis showed that SIRS duration, obesity, CRP, WBC, blood urea nitrogen, PN, ANC, SAP, MODS, RANSON score, BISAP score, and CTSI score were risk factors for IPN in patients with AP (all P < 0.05), and the multivariate analysis showed that SIRS duration (odds ratio [OR]=1.307, 95% confidence interval [CI]: 1.081-1.580, P=0.006) and ANC (OR=42.247, 95% CI: 10.829-164.818, P < 0.001) were risk factors for IPN; when ANC was excluded, SIRS duration (OR=1.430, 95% CI: 1.207-1.694, P < 0.001) and PN (OR=5.296, 95% CI: 1.845-15.203, P=0.002) were risk factors for IPN. The ROC curve showed that SIRS duration (AUC=0.772, Youden index=0.521), RANSON score (AUC=0.701, Youden index=0.319), BISAP score (AUC=0.741, Youden index=0.377), and CTSI score (AUC=0.765, Youden Index=0.414) had a certain value in predicting IPN, and there was no significant difference in AUC between any two indices. The long-duration SIRS group (> 4 d) had a significantly higher proportion of patients with PN, ANC, IPN, SAP, or CAP than the non-SIRS group (0 d), the transient SIRS group (1~2 d), and the persistent SIRS group (3~4 d) (all P < 0.05), and the persistent SIRS group had a significantly higher proportion of patients with SAP than the non-SIRS group (P < 0.05).  Conclusion  AP patients with SIRS in the early stage are likely to develop organ failure and local complications, and there is a significant increase in the risk of IPN when SIRS duration is > 4.5 days.

     

    • FullText(HTML)
    • References(31)
  • [1]
    Pancreas Study Group, Chinese Society of Gastroenterology, Chinese Medical Association; Editorial Board of Chinese Journal of Pancreatology; Editorial Board of Chinese Journal of Digestion. Chinese guidelines for the management of acute pancreatitis (Shenyang, 2019)[J]. J Clin Hepatol, 2019, 35(12): 2706-2711. (in Chinese)

    中华医学会消化病学分会胰腺疾病学组, 《中华胰腺病杂志》编委会, 《中华消化杂志》编委会. 中国急性胰腺炎诊治指南(2019年, 沈阳)[J]. 临床肝胆病杂志, 2019, 35(12): 2706-2711.
    [2]
    LEPPÄNIEMI A, TOLONEN M, TARASCONI A, et al. 2019 WSES guidelines for the management of severe acute pancreatitis[J]. World J Emerg Surg, 2019, 14: 27. DOI: 10.1186/s13017-019-0247-0
    [3]
    TAN C, YANG L, SHI F, et al. Early systemic inflammatory response syndrome duration predicts infected pancreatic necrosis[J]. J Gastrointest Surg, 2020, 24(3): 590-597. DOI: 10.1007/s11605-019-04149-5
    [4]
    SILVA-VAZ P, ABRANTES AM, MORGADO-NUNES S, et al. Evaluation of prognostic factors of severity in acute biliary pancreatitis[J]. Int J Mol Sci, 2020, 21(12) : 4300. DOI: 10.3390/ijms21124300
    [5]
    VENKATESH NR, VIJAYAKUMAR C, BALASUBRAMANIYAN G, et al. Comparison of different scoring systems in predicting the severity of acute pancreatitis: A prospective observational study[J]. Cureus, 2020, 12(2): e6943. http://www.researchgate.net/publication/339176836_Comparison_of_Different_Scoring_Systems_in_Predicting_the_Severity_of_Acute_Pancreatitis_A_Prospective_Observational_Study
    [6]
    SOULOUNTSI V, SCHIZODIMOS T. Use of antibiotics in acute pancreatitis: Ten major concerns[J]. Scand J Gastroenterol, 2020, 55(10): 1211-1218. DOI: 10.1080/00365521.2020.1804995
    [7]
    CASE BM, JENSEN KK, BAKIS G, et al. Endoscopic interventions in acute pancreatitis: What the advanced endoscopist wants to know[J]. Radiographics, 2018, 38(7): 2002-2018. DOI: 10.1148/rg.2018180066
    [8]
    ARVANITAKIS M, DUMONCEAU JM, ALBERT J, et al. Endoscopic management of acute necrotizing pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) evidence-based multidisciplinary guidelines[J]. Endoscopy, 2018, 50(5): 524-546. DOI: 10.1055/a-0588-5365
    [9]
    TRIKUDANATHAN G, WOLBRINK D, van SANTVOORT HC, et al. Current concepts in severe acute and necrotizing pancreatitis: An evidence-based approach[J]. Gastroenterology, 2019, 156(7): 1994-2007. DOI: 10.1053/j.gastro.2019.01.269
    [10]
    SHARMA D, JAKKAMPUDI A, REDDY R, et al. Association of systemic inflammatory and anti-inflammatory responses with adverse outcomes in acute pancreatitis: Preliminary results of an ongoing study[J]. Dig Dis Sci, 2017, 62(12): 3468-3478. DOI: 10.1007/s10620-017-4813-6
    [11]
    SENDLER M, van den BRANDT C, GLAUBITZ J, et al. NLRP3 inflammasome regulates development of systemic inflammatory response and compensatory anti-inflammatory response syndromes in mice with acute pancreatitis[J]. Gastroenterology, 2020, 158(1): 253-269. DOI: 10.1053/j.gastro.2019.09.040
    [12]
    YANG R, TENHUNEN J, TONNESSEN TI. HMGB1 and histones play a significant role in inducing systemic inflammation and multiple organ dysfunctions in severe acute pancreatitis[J]. Int J Inflam, 2017, 2017: 1817564. http://www.ncbi.nlm.nih.gov/pubmed/28316860
    [13]
    CHEN Z, DONG WH, WU Q, et al. Two-layer regulation of TRAF6 mediated by both TLR4/NF-kB signaling and miR-589-5p increases proinflammatory cytokines in the pathology of severe acute pancreatitis[J]. Am J Transl Res, 2020, 12(6): 2379-2395. http://www.zhangqiaokeyan.com/academic-journal-foreign-pmc_american-journal-translational-research_thesis/040006415721.html
    [14]
    IYER S, BAWA EP, TARIQUE M, et al. Know thy enemy-understanding the role of inflammation in severe acute pancreatitis[J]. Gastroenterology, 2020, 158(1): 46-48. DOI: 10.1053/j.gastro.2019.11.039
    [15]
    DIXIT A, CHEEMA H, GEORGE J, et al. Extracellular release of ATP promotes systemic inflammation during acute pancreatitis[J]. Am J Physiol Gastrointest Liver Physiol, 2019, 317(4): g463-g475. DOI: 10.1152/ajpgi.00395.2018
    [16]
    DUMNICKA P, MADUZIA D, CERANOWICZ P, et al. The interplay between inflflammation, coagulation and endothelial injury in the early phase of acute pancreatitis: Clinical implications[J]. Int J Mol Sci, 2017, 18(2): 354. DOI: 10.3390/ijms18020354
    [17]
    GAD MM, SIMONS-LINARES CR. Is aggressive intravenous fluid resuscitation beneficial in acute pancreatitis? A meta-analysis of randomized control trials and cohort studies[J]. World J Gastroenterol, 2020, 26(10): 1098-1106. DOI: 10.3748/wjg.v26.i10.1098
    [18]
    YE B, MAO W, CHEN Y, et al. Aggressive resuscitation is associated with the development of acute kidney injury in acute pancreatitis[J]. Dig Dis Sci, 2019, 64(2): 544-552. DOI: 10.1007/s10620-018-5328-5
    [19]
    CHOOSAKUL S, HARINWAN K, CHIRAPONGSATHORN S, et al. Comparison of normal saline versus Lactated Ringer's solution for fluid resuscitation in patients with mild acute pancreatitis, A randomized controlled trial[J]. Pancreatology, 2018, 18(5): 507-512. DOI: 10.1016/j.pan.2018.04.016
    [20]
    FROGHI F, SOGGIU F, RICCIARDI F, et al. Ward-based goal-directed fluid therapy (GDFT) in acute pancreatitis (GAP) trial: Study protocol for a feasibility randomised controlled trial[J]. BMJ Open, 2019, 9(10): e028783. DOI: 10.1136/bmjopen-2018-028783
    [21]
    WOLBRINK D, GRUNDSELL JR, WITTEMAN B, et al. Are omega-3 fatty acids safe and effective in acute pancreatitis or sepsis? A systematic review and meta-analysis[J]. Clin Nutr, 2020, 39(9): 2686-2694. DOI: 10.1016/j.clnu.2019.12.006
    [22]
    RUIZ-REBOLLO ML, MUÑOZ-MORENO MF, MAYO-ISCAR A, et al. Statin intake can decrease acute pancreatitis severit[J]. Pancreatology, 2019, 19(6): 807-812. DOI: 10.1016/j.pan.2019.07.004
    [23]
    JIANG X, SHI JY, WANG XY, et al. The impacts of infectious complications on outcomes in acute pancreatitis: A retrospective study[J]. Mil Med Res, 2020, 7(1): 38. http://www.researchgate.net/publication/343685598_The_impacts_of_infectious_complications_on_outcomes_in_acute_pancreatitis_a_retrospective_study
    [24]
    TIAN H, CHEN L, WU X, et al. Infectious complications in severe acute pancreatitis: Pathogens, drug resistance, and status of nosocomial infection in a university-affiliated teaching hospital[J]. Dig Dis Sci, 2020, 65(7): 2079-2088. DOI: 10.1007/s10620-019-05924-9
    [25]
    BARON TH, DIMAIO CJ, WANG AY, et al. American Gastroenterological association clinical practice update: Management of pancreatic necrosis[J]. Gastroenterology, 2020, 158(1): 67-75. DOI: 10.1053/j.gastro.2019.07.064
    [26]
    SUSAK YM, DIRDA OO, FEDORCHUK OG, et al. Infectious complications of acute pancreatitis is associated with peripheral blood phagocyte functional exhaustion[J]. Dig Dis Sci, 2020.[Online ahead of print]
    [27]
    LU JD, CAO F, DING YX, et al. Timing, distribution, and microbiology of infectious complications after necrotizing pancreatitis[J]. World J Gastroenterol, 2019, 25(34): 5162-5173. DOI: 10.3748/wjg.v25.i34.5162
    [28]
    AUSANIA F, SENRA DEL RÍO P, BORIN A, et al. Factors associated with mortality in patients with infected pancreatic necrosis: The "surgery effect"[J]. Updates Surg, 2020, 72(4): 1097-1103. DOI: 10.1007/s13304-020-00764-z
    [29]
    ZHANG ZH, DING YX, WU YD, et al. A meta-analysis and systematic review of percutaneous catheter drainage in treating infected pancreatitis necrosis[J]. Medicine (Baltimore), 2018, 97(47): e12999. DOI: 10.1097/MD.0000000000012999
    [30]
    DARRIVERE L, LAPIDUS N, COLIGNON N, et al. Minimally invasive drainage in critically ill patients with severe necrotizing pancreatitis is associated with better outcomes: An observational study[J]. Crit Care, 2018, 22(1): 321. DOI: 10.1186/s13054-018-2256-x
    [31]
    SUN B, LI GQ. Surgical intervention strategies for local complications of severe acute pancreatitis[J]. Chin J Dig Surg, 2020, 19(4): 379-383. (in Chinese)
    • Relative Articles

  • Relative Articles

    [1]Xuyang WANG, Zhangpeng WANG, Jun WU, Guangxu JING, Zhu HUANG, Hongyu SUN, Lijun TANG. Effect of early thoracic paracentesis drainage on acute lung injury in severe acute pancreatitis[J]. Journal of Clinical Hepatology, 2023, 39(7): 1633-1642. doi: 10.3969/j.issn.1001-5256.2023.07.018
    [2]Rongjie LI, Yi PENG, Xiaolong TANG, Decai ZHANG, Shaojun LIU. Establishment of a modified BISAP scoring system and its clinical significance in the early diagnosis and prognostic evaluation of severe acute pancreatitis[J]. Journal of Clinical Hepatology, 2023, 39(10): 2432-2442. doi: 10.3969/j.issn.1001-5256.2023.10.022
    [3]Minyue YIN, Jinzhou ZHU, Lu LIU, Jingwen GAO, Jiaxi LIN, Chunfang XU. Research advances in machine learning models for acute pancreatitis[J]. Journal of Clinical Hepatology, 2023, 39(12): 2978-2984. doi: 10.3969/j.issn.1001-5256.2023.12.034
    [4]Heming HUANG, Huiying YANG, Yingying QIN, Guodu TANG. Relationship between visceral fat related index and the severity of acute pancreatitis[J]. Journal of Clinical Hepatology, 2022, 38(10): 2313-2319. doi: 10.3969/j.issn.1001-5256.2022.10.021
    [5]Wenqian XU, Min GUO, Xiao WANG, Yaoqi WU, Jinyuan ZHANG, Heguo LI. Molecular mechanism of liver injury in acute pancreatitis[J]. Journal of Clinical Hepatology, 2022, 38(11): 2663-2668. doi: 10.3969/j.issn.1001-5256.2022.11.045
    [7]Ma Min, Zhou ZhongYin. A comparative analysis of acute pancreatitis and hyperamylasemia after endoscopic retrograde cholangiopancreatography[J]. Journal of Clinical Hepatology, 2020, 36(2): 395-398. doi: 10.3969/j.issn.1001-5256.2020.02.033
    [8]CAO Fei, PAN ChangBao, XU QingCheng, CHEN WeiWei, DENG DengHao, XIANG XiaoXing, CHEN Juan. Treatment of recurrent acute pancreatitis caused by incomplete pancreatic divisum via stent implantation of the accessory pancreatic duct by a reversed guide wire through the main pancreatic duct: A case report[J]. Journal of Clinical Hepatology, 2020, 36(12): 2805-2807. doi: 10.3969/j.issn.1001-5256.2020.12.033
    [9]LIU Hui, LI XianQiu, LUO Gang, TANG ShiXiao. Risk factors for new-onset diabetes after incipient acute pancreatitis[J]. Journal of Clinical Hepatology, 2020, 36(12): 2771-2776. doi: 10.3969/j.issn.1001-5256.2020.12.026
    [10]ZHANG Ting, LI Ting, HUANG YuMei, WANG 烜. Value of body fat parameters in predicting the severity of acute pancreatitis[J]. Journal of Clinical Hepatology, 2020, 36(12): 2761-2764. doi: 10.3969/j.issn.1001-5256.2020.12.024
    [11]Lyu NongHua, He WenHua. Endoscopic therapy for acute pancreatitis[J]. Journal of Clinical Hepatology, 2020, 36(8): 1688-1690. doi: 10.3969/j.issn.1001-5256.2020.08.002
    [12]Wu DongDong, Yang XiaoYan, Gao Feng. Research advances in minimally invasive treatment of infectious pancreatic necrosis[J]. Journal of Clinical Hepatology, 2017, 33(4): 785-789. doi: 10.3969/j.issn.1001-5256.2017.04.042
    [13]Hou Fei, Liu RuiXia, Yin ChengHong. Pathogenetic mechanism of microcirculatory disturbance and treatment advances in acute pancreatitis[J]. Journal of Clinical Hepatology, 2014, 30(8): 815-818. doi: 10.3969/j.issn.1001-5256.2014.08.033
    [14]Pancreas Study Group, Chinese Society of Gastroenterology, Chinese Medical Association, Editorial Board of Chinese Journal of Pancreatology, Editorial Board of Chinese Journal of Digestion. Chinese guidelines for the management of acute pancreatitis ( Shanghai, 2013)[J]. Journal of Clinical Hepatology, 2013, 29(9): 656-660. doi: 10.3969/j.issn.1001-5256.2013.09.006
    [15]Liu ChengYi, Chen YanDong. Measurement of serum leptin level in acute pancreatitis patients[J]. Journal of Clinical Hepatology, 2009, 25(6): 437-439.
    [16]Zhang MingWei, Wang Xin, Zhang Jing. The correlation between TAP levels in plasma and urine and severity in patients with acute pancreatitis and their clinical significances[J]. Journal of Clinical Hepatology, 2007, 23(6): 448-449.
    [19]You Zhen, Zhang XueChun. The relationship of TNF-α、IL-6 in portal vein and hepatic damage in SAP rats[J]. Journal of Clinical Hepatology, 2004, 20(5): 295-296.
    [20]Zhang Jing, Zhao Jun, Li SanJun, Dan Jing, Wang Fang, Duan ZhongPing. Clinical features of liver injury in SARS patients with system inflammatory reaction syndrome[J]. Journal of Clinical Hepatology, 2003, 19(6): 339-341.
    • Supplements(0)
    • Cited By

  • Cited by

    Periodical cited type(23)

    1. 李丹丹，王明选，沈小程，潘金，王春微. 柴芍承气汤保留灌肠联合九合丹外敷治疗肝胃实热证急性胰腺炎的效果观察. 临床误诊误治. 2025(02): 72-76 .
    2. 李存刚，李新生. 血清降钙素原、中性粒细胞/淋巴细胞比值、血小板/淋巴细胞比值与急性胰腺炎患者病情严重程度的相关性. 中国民康医学. 2025(04): 148-150 .
    3. 孙文英. 急性重症胰腺炎患者继发感染性胰腺坏死的影响因素. 内科. 2024(01): 102-105 .
    4. 邢果果，赵江华. 三七总皂苷防治重症急性胰腺炎多器官损伤的临床效果. 实用中西医结合临床. 2024(08): 49-51 .
    5. 刘晓荣，杨金艳. 乌司他丁联合生长抑素治疗重症急性胰腺炎的疗效及对患者血清TNF-a、IL-6、CRP水平的影响. 海南医学. 2023(02): 194-197 .
    6. 张永华，杨国红，马素平，王晨晓，张秀梅，李春颖，张丽慧，王晓. 急性胰腺炎发作时间与人体阴阳昼夜节律初探. 中医学报. 2023(02): 432-437 .
    7. 栗朋辉. 血清hs-CRP、IL-18与急性胰腺炎患者感染性胰腺坏死发生的相关性. 罕少疾病杂志. 2023(01): 60-62 .
    8. 刘琢玉，黄小华，明兵，唐玲玲，胡云涛，贾清. CT纹理分析预测急性胰腺炎患者并发全身炎症反应综合征的研究. 临床放射学杂志. 2023(03): 428-433 .
    9. 侯虹燕，韩丹. 改良CT严重指数评分联合实验室指标对急性胰腺炎严重程度的预测价值. 影像研究与医学应用. 2023(08): 194-196 .
    10. 刘会雪，牛立远，张佩佩，安江科，魏贯南. 急性胰腺炎病人血清长链非编码RNA核富集转录体1、Toll样受体2表达变化及临床意义研究. 安徽医药. 2023(09): 1814-1818 .
    11. 敖雪，邓超，吴生赞. 重症胰腺炎患者血清载脂蛋白B/载脂蛋白A1、微管相关蛋白1-轻链3和细胞间黏附分子-1水平在预测并发感染性胰腺坏死中的价值. 国际检验医学杂志. 2023(17): 2074-2079 .
    12. 王凯，王聪，杨惠珍. 谷氨酰胺联合乌司他丁对急性胰腺炎患者血清指标的影响及最佳用药剂量分析. 淮海医药. 2023(05): 505-508 .
    13. 陈鲲鹏，张丽丽. 血清肌酐 胱抑素C 血尿素氮对重症急性胰腺炎并发急性肾损伤的预测效能. 实用医技杂志. 2023(08): 538-542 .
    14. 贺宇兰. 微生态肠内营养联合耳穴压豆对重症胰腺炎的干预效果. 中外医学研究. 2023(32): 58-61 .
    15. 刘星星. 奥曲肽联合乌司他丁治疗急性胰腺炎患者效果观察. 北方药学. 2023(10): 103-105+108 .
    16. 王云，刘德仁，冯如，陶生. 依诺肝素联合胰岛素治疗中度重症高脂血症型急性胰腺炎的安全性分析. 系统医学. 2023(19): 93-95+100 .
    17. 李召龙，安霞，张宏伟. 血必净联合血液灌流对SAP患者线粒体炎症通路及血脂水平的影响. 国际医药卫生导报. 2023(24): 3633-3637 .
    18. 沙如拉，秦瑞海，王熠伟，达胡拉巴艺拉. 细胞坏死抑制剂TAK-632治疗急性胰腺炎的疗效及分子机制. 实用临床医药杂志. 2022(07): 120-123 .
    19. 张英，张建茹，张雨，汪敬杰，石小平. 柴芩攻毒方灌肠联合电针治疗重症急性胰腺炎湿热毒瘀证35例. 环球中医药. 2022(06): 1091-1094 .
    20. 巫泓生，马克强，廖碧玲，嵇腾飞，黄健斌，曹天生. 无创心排量联合中心静脉血氧饱和度监测对高脂血症性重症胰腺炎早期目标导向性液体复苏的指导作用. 临床肝胆病杂志. 2022(07): 1602-1607 . 本站查看
    21. 冯海娟，陈恳，丁益宏. 血清HBDH、GIP和s IL-2R对急性胰腺炎严重程度的早期评估价值. 现代消化及介入诊疗. 2022(08): 1026-1029 .
    22. 黄一赫. 连续性肾脏替代疗法联合异甘草酸镁注射液对重症急性胰腺炎患者炎症及预后疗效评价. 系统医学. 2022(22): 120-123 .
    23. 刘静静. 中医通里攻下法联合早期微生态肠内营养治疗重症急性胰腺炎的临床效果及对炎症反应的影响. 实用中医内科杂志. 2021(10): 74-76 .

    Other cited types(4)

  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 14.2 %FULLTEXT: 14.2 %META: 79.5 %META: 79.5 %PDF: 6.3 %PDF: 6.3 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 8.0 %其他: 8.0 %其他: 2.3 %其他: 2.3 %Bengaluru: 0.2 %Bengaluru: 0.2 %China: 0.1 %China: 0.1 %Elizabeth City: 0.2 %Elizabeth City: 0.2 %Germany: 0.2 %Germany: 0.2 %Greece: 0.1 %Greece: 0.1 %India: 0.8 %India: 0.8 %Mexico: 0.3 %Mexico: 0.3 %San Lorenzo: 0.1 %San Lorenzo: 0.1 %Taiwan, China: 0.2 %Taiwan, China: 0.2 %United States: 0.5 %United States: 0.5 %[]: 0.8 %[]: 0.8 %上海: 2.4 %上海: 2.4 %东莞: 0.2 %东莞: 0.2 %丽水: 0.1 %丽水: 0.1 %佛山: 0.1 %佛山: 0.1 %保定: 0.4 %保定: 0.4 %六安: 0.2 %六安: 0.2 %兰州: 0.1 %兰州: 0.1 %北京: 3.7 %北京: 3.7 %南京: 0.8 %南京: 0.8 %南充: 0.1 %南充: 0.1 %南宁: 0.2 %南宁: 0.2 %南昌: 0.1 %南昌: 0.1 %台州: 0.2 %台州: 0.2 %合肥: 0.2 %合肥: 0.2 %吉林: 1.6 %吉林: 1.6 %哥伦布: 0.1 %哥伦布: 0.1 %天津: 0.3 %天津: 0.3 %奥里萨: 0.3 %奥里萨: 0.3 %娄底: 0.1 %娄底: 0.1 %宁波: 0.3 %宁波: 0.3 %安顺: 0.1 %安顺: 0.1 %常德: 0.1 %常德: 0.1 %广州: 0.5 %广州: 0.5 %库比蒂诺: 0.3 %库比蒂诺: 0.3 %弗吉: 0.1 %弗吉: 0.1 %张家口: 2.0 %张家口: 2.0 %德阳: 0.2 %德阳: 0.2 %成都: 0.9 %成都: 0.9 %拉贾斯坦邦: 0.3 %拉贾斯坦邦: 0.3 %旁遮普: 0.8 %旁遮普: 0.8 %昆明: 0.5 %昆明: 0.5 %晋城: 0.1 %晋城: 0.1 %杭州: 0.6 %杭州: 0.6 %武汉: 0.5 %武汉: 0.5 %永州: 0.1 %永州: 0.1 %泸州: 0.2 %泸州: 0.2 %济南: 0.3 %济南: 0.3 %深圳: 0.3 %深圳: 0.3 %湘潭: 0.1 %湘潭: 0.1 %漯河: 0.2 %漯河: 0.2 %石家庄: 0.1 %石家庄: 0.1 %福州: 0.6 %福州: 0.6 %秦皇岛: 0.1 %秦皇岛: 0.1 %芒廷维尤: 37.8 %芒廷维尤: 37.8 %芝加哥: 0.4 %芝加哥: 0.4 %苏州: 0.1 %苏州: 0.1 %荆门: 0.1 %荆门: 0.1 %莫斯科: 3.3 %莫斯科: 3.3 %萨默维尔: 0.1 %萨默维尔: 0.1 %衢州: 0.4 %衢州: 0.4 %西宁: 12.4 %西宁: 12.4 %西安: 0.2 %西安: 0.2 %贵港: 0.2 %贵港: 0.2 %贵阳: 0.3 %贵阳: 0.3 %赤峰: 0.2 %赤峰: 0.2 %运城: 1.5 %运城: 1.5 %郑州: 0.1 %郑州: 0.1 %重庆: 0.2 %重庆: 0.2 %金华: 0.1 %金华: 0.1 %长春: 4.9 %长春: 4.9 %长沙: 0.6 %长沙: 0.6 %长治: 0.1 %长治: 0.1 %雅安: 0.2 %雅安: 0.2 %青岛: 0.1 %青岛: 0.1 %首尔特别: 1.1 %首尔特别: 1.1 %马鞍山: 0.1 %马鞍山: 0.1 %驻马店: 0.1 %驻马店: 0.1 %高雄: 0.2 %高雄: 0.2 %黄冈: 0.1 %黄冈: 0.1 %其他其他BengaluruChinaElizabeth CityGermanyGreeceIndiaMexicoSan LorenzoTaiwan, ChinaUnited States[]上海东莞丽水佛山保定六安兰州北京南京南充南宁南昌台州合肥吉林哥伦布天津奥里萨娄底宁波安顺常德广州库比蒂诺弗吉张家口德阳成都拉贾斯坦邦旁遮普昆明晋城杭州武汉永州泸州济南深圳湘潭漯河石家庄福州秦皇岛芒廷维尤芝加哥苏州荆门莫斯科萨默维尔衢州西宁西安贵港贵阳赤峰运城郑州重庆金华长春长沙长治雅安青岛首尔特别马鞍山驻马店高雄黄冈

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(6)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (737) PDF downloads(59) Cited by(27)
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[2008]YesterdayPV[3584]TodayIP[1340]TodayPV[2481]Online[99]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return